BSE filing, NSE: RECLTD. Summary written from the filing by ALFA Finder's alert engine.
REC Ltd: key numbers
- Share price
- ₹290.00
- Market cap
- ₹76,364 Cr
- Revenue (annual)
- ₹59,584 Cr
- Net profit (annual)
- ₹16,308 Cr
- P/E (TTM)
- 5.1×Sector 19.7×
- Promoter holding
- 52.63%+0.00% QoQ
- FII holding
- 16.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from REC Ltd
All →REC Dividend
REC Limited declared an interim dividend of Rs.3.5 per share for 2026-27. Record date is 30 October 2026, with payment by 21 November 2026.
REC Q2 FY27 Results: Net Profit ₹3,478 Cr, Down 21.2% YoY
REC Ltd reported revenue from operations of ₹15,000 Cr (-1.0% YoY) and net profit of ₹3,478 Cr (-21.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3,478 Cr · -21.2% YoY
REC Merger & Restructuring Worth ₹0.05 Cr
REC Limited disclosed incorporation of Bikaner V Part D Power Transmission Limited, a wholly owned subsidiary via RECPDCL. Cash consideration of ₹0.05 Crore was paid for 100% subscription.
- Value
- ₹0.05 Cr
REC Merger & Restructuring
REC Limited disclosed incorporation of three wholly owned power transmission subsidiaries. Each has paid-up capital of ₹5,00,000 and no turnover yet.
REC Debt & Borrowing: ₹3,000 Cr
REC Limited successfully completed the full redemption of Commercial Papers worth ₹3,000 Crore on the maturity date of October 22, 2026.
- Value
- ₹3,000 Cr
REC Debt & Borrowing
REC Limited confirmed the timely redemption and payment of its commercial papers due on October 22, 2026, in compliance with SEBI regulations.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.